chr11-61720167-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_ModerateBP6BP7BS2
The NM_006133.3(DAGLA):c.12C>T(p.Ile4Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000999 in 1,612,976 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.00068 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0010 ( 3 hom. )
Consequence
DAGLA
NM_006133.3 synonymous
NM_006133.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.571
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.27).
BP6
Variant 11-61720167-C-T is Benign according to our data. Variant chr11-61720167-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 3052577.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=0.571 with no splicing effect.
BS2
High AC in GnomAd4 at 104 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DAGLA | NM_006133.3 | c.12C>T | p.Ile4Ile | synonymous_variant | 2/20 | ENST00000257215.10 | NP_006124.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DAGLA | ENST00000257215.10 | c.12C>T | p.Ile4Ile | synonymous_variant | 2/20 | 1 | NM_006133.3 | ENSP00000257215.5 | ||
DAGLA | ENST00000540717.1 | n.12C>T | non_coding_transcript_exon_variant | 2/20 | 5 | ENSP00000440264.1 |
Frequencies
GnomAD3 genomes AF: 0.000683 AC: 104AN: 152204Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
104
AN:
152204
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000830 AC: 208AN: 250622Hom.: 0 AF XY: 0.000856 AC XY: 116AN XY: 135574
GnomAD3 exomes
AF:
AC:
208
AN:
250622
Hom.:
AF XY:
AC XY:
116
AN XY:
135574
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00103 AC: 1507AN: 1460772Hom.: 3 Cov.: 30 AF XY: 0.00103 AC XY: 751AN XY: 726772
GnomAD4 exome
AF:
AC:
1507
AN:
1460772
Hom.:
Cov.:
30
AF XY:
AC XY:
751
AN XY:
726772
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000683 AC: 104AN: 152204Hom.: 0 Cov.: 33 AF XY: 0.000471 AC XY: 35AN XY: 74344
GnomAD4 genome
AF:
AC:
104
AN:
152204
Hom.:
Cov.:
33
AF XY:
AC XY:
35
AN XY:
74344
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
DAGLA-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 10, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at